MICSI builds vendor-neutral software that improves clinical image quality, starting with our FDA-cleared MRI enhancement (MICSI-RMT) for noise and artifact reduction, enabling faster scans and better performance on low-end or aging MRI scanners. Our next product focuses on PET imaging (targeting FDA clearance in Q2 2026). We use the patient’s prior MRI to reduce noise and recover resolution in PET across vendors, enabling lower-dose scans and extending the useful life of existing scanners. We acquire customers via champion-led pilots that expand into scaled deployments, amplified by reference sites and conferences.